Matches in SemOpenAlex for { <https://semopenalex.org/work/W2235256585> ?p ?o ?g. }
Showing items 1 to 100 of
100
with 100 items per page.
- W2235256585 abstract "The in vitro sensitivity of Helicobacter pylori to rifaximin, a new rffamycin antibiotic, was evaluated in 40 clinical isolates by the agar dilution method. Rifaximin showed good activity, with a 50% minimum inhibitory concentration of 4 mg/L -1. Consequently, we assessed rifaximin in Hpylori-positive patients. Overall, 71 patients with upper gastrointestinal symptoms (35 men and 36 women; aged 19 to 73 years, mean, 45.6 years) were found to have H pyloriassociated gastritis. The first 30 consecutive patients received monotherapy with rifaximin 600 mg three times a day (T1D) for 14 days. The 41 patients enrolled thereafter were allocated in an open, randomized fashion to four different treatment groups for 14 days: (1) rifaximin 600 mg TID and colloidal bismuth subcitrate 240 mg twice a day (BID) (n = 10); (2) rifaximin 600 mg TID and omeprazole 20 mg BID (n = 10); (3) rifaximin 600 mg TID and amoxicillin I g BID (n = 10); or (4) rifaximin 1800 mg TID and metronidazole 500 mg TID (n = 11). Upper gastrointestinal symptoms (pyrosis, bloating, epigastric pain, and nausea) were recorded and assessed before and 4 weeks after treatment. Patients were assessed by endoscopy, histology, CP test, culture, and serology (immunoglobulin G [IgG] to H pylori) at entry. Sixty-seven patients were available for follow-up 4 weeks after the completion of treatment. A statistically significant improvement in symptoms was seen in patients treated with rifaximin and rifaximin plus colloidal bismuth subcitrate. No statistically significant differences in degree of improvement in endoscopic and histologic findings were seen among the five treatment groups. A statistically significant decrease in the mean IgG value after treatment was found for rifaximin, rifaximin pins colloidal bismuth subcitrate, and rifaximin plus omeprazole. The overall eradication rate was 43%. These results suggest that rifaximin may be an effective antibiotic against Hpylori infection and is worthy of further study." @default.
- W2235256585 created "2016-06-24" @default.
- W2235256585 creator A5005115254 @default.
- W2235256585 creator A5006019843 @default.
- W2235256585 creator A5008990417 @default.
- W2235256585 creator A5017281579 @default.
- W2235256585 creator A5022747830 @default.
- W2235256585 creator A5023839648 @default.
- W2235256585 creator A5036993654 @default.
- W2235256585 creator A5057363960 @default.
- W2235256585 creator A5067159913 @default.
- W2235256585 creator A5068462651 @default.
- W2235256585 creator A5069546099 @default.
- W2235256585 creator A5081143505 @default.
- W2235256585 creator A5082627820 @default.
- W2235256585 creator A5084870081 @default.
- W2235256585 date "1997-01-01" @default.
- W2235256585 modified "2023-09-26" @default.
- W2235256585 title "Rifaximin suspension for the dradication of Helicobacter pylori" @default.
- W2235256585 cites W1979077320 @default.
- W2235256585 cites W1986834847 @default.
- W2235256585 cites W1995808929 @default.
- W2235256585 cites W1996233506 @default.
- W2235256585 cites W2006858201 @default.
- W2235256585 cites W2072396675 @default.
- W2235256585 cites W2103367458 @default.
- W2235256585 cites W2138438059 @default.
- W2235256585 cites W2152698196 @default.
- W2235256585 cites W2404208968 @default.
- W2235256585 cites W2424900100 @default.
- W2235256585 cites W2436393922 @default.
- W2235256585 cites W2470035426 @default.
- W2235256585 hasPublicationYear "1997" @default.
- W2235256585 type Work @default.
- W2235256585 sameAs 2235256585 @default.
- W2235256585 citedByCount "0" @default.
- W2235256585 crossrefType "journal-article" @default.
- W2235256585 hasAuthorship W2235256585A5005115254 @default.
- W2235256585 hasAuthorship W2235256585A5006019843 @default.
- W2235256585 hasAuthorship W2235256585A5008990417 @default.
- W2235256585 hasAuthorship W2235256585A5017281579 @default.
- W2235256585 hasAuthorship W2235256585A5022747830 @default.
- W2235256585 hasAuthorship W2235256585A5023839648 @default.
- W2235256585 hasAuthorship W2235256585A5036993654 @default.
- W2235256585 hasAuthorship W2235256585A5057363960 @default.
- W2235256585 hasAuthorship W2235256585A5067159913 @default.
- W2235256585 hasAuthorship W2235256585A5068462651 @default.
- W2235256585 hasAuthorship W2235256585A5069546099 @default.
- W2235256585 hasAuthorship W2235256585A5081143505 @default.
- W2235256585 hasAuthorship W2235256585A5082627820 @default.
- W2235256585 hasAuthorship W2235256585A5084870081 @default.
- W2235256585 hasConcept C126322002 @default.
- W2235256585 hasConcept C2776409635 @default.
- W2235256585 hasConcept C2778677798 @default.
- W2235256585 hasConcept C2778889925 @default.
- W2235256585 hasConcept C2780580376 @default.
- W2235256585 hasConcept C2780708398 @default.
- W2235256585 hasConcept C501593827 @default.
- W2235256585 hasConcept C71924100 @default.
- W2235256585 hasConcept C86803240 @default.
- W2235256585 hasConcept C89423630 @default.
- W2235256585 hasConcept C90924648 @default.
- W2235256585 hasConceptScore W2235256585C126322002 @default.
- W2235256585 hasConceptScore W2235256585C2776409635 @default.
- W2235256585 hasConceptScore W2235256585C2778677798 @default.
- W2235256585 hasConceptScore W2235256585C2778889925 @default.
- W2235256585 hasConceptScore W2235256585C2780580376 @default.
- W2235256585 hasConceptScore W2235256585C2780708398 @default.
- W2235256585 hasConceptScore W2235256585C501593827 @default.
- W2235256585 hasConceptScore W2235256585C71924100 @default.
- W2235256585 hasConceptScore W2235256585C86803240 @default.
- W2235256585 hasConceptScore W2235256585C89423630 @default.
- W2235256585 hasConceptScore W2235256585C90924648 @default.
- W2235256585 hasLocation W22352565851 @default.
- W2235256585 hasOpenAccess W2235256585 @default.
- W2235256585 hasPrimaryLocation W22352565851 @default.
- W2235256585 hasRelatedWork W136883411 @default.
- W2235256585 hasRelatedWork W191503867 @default.
- W2235256585 hasRelatedWork W1967608131 @default.
- W2235256585 hasRelatedWork W2007806685 @default.
- W2235256585 hasRelatedWork W2076362027 @default.
- W2235256585 hasRelatedWork W2096838586 @default.
- W2235256585 hasRelatedWork W2112712844 @default.
- W2235256585 hasRelatedWork W2151678454 @default.
- W2235256585 hasRelatedWork W219528671 @default.
- W2235256585 hasRelatedWork W2358950345 @default.
- W2235256585 hasRelatedWork W2365448922 @default.
- W2235256585 hasRelatedWork W2373386463 @default.
- W2235256585 hasRelatedWork W2374596562 @default.
- W2235256585 hasRelatedWork W2405149186 @default.
- W2235256585 hasRelatedWork W2411214845 @default.
- W2235256585 hasRelatedWork W2415461970 @default.
- W2235256585 hasRelatedWork W3029045203 @default.
- W2235256585 hasRelatedWork W34453594 @default.
- W2235256585 hasRelatedWork W68235758 @default.
- W2235256585 hasRelatedWork W867217690 @default.
- W2235256585 isParatext "false" @default.
- W2235256585 isRetracted "false" @default.
- W2235256585 magId "2235256585" @default.
- W2235256585 workType "article" @default.